๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
NCT04380636Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC
Phase 3
870
Beijing, Chongqing, Fuzhou, Xiamen, Shenzhen, Zhengzhou, Wuhan, Changsha
2020-07-06
Recruiting
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
NCT04275518Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Ascentage Pharma Group Inc.
Phase 1
102
Beijing, Guangzhou, Zhengzhou, Wuhan, Changsha, Suzhou, Nanchang, Changchun
2020-07-06
Recruiting
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
NCT04453813Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
Sun Yat-sen University
Phase 3
226
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-07-03
Recruiting
Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
NCT05314114Breast Cancer Female
Peking University
Not applicable
136
Beijing
2020-07-03
Active, closed
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
NCT04111419Atrial Fibrillation, Hypertension
Shanghai Jiao Tong University School of Medicine
Phase 4
1,200
Shanghai
2020-07-01
Recruiting
Advanced Translational Research on Childhood Leukemia
NCT04478006Childhood Leukemia
Chinese University of Hong Kong
Observational
300
Hong Kong
2020-07-01
Active, closed
The Efficacy and Safety of Adjuvant Immunotherapy After Pathological Complete Response Following Neoadjuvant Chemoimmunotherapy in Patients with Resectable NSCLC
NCT06243679Resectable/Potentially Resectable NSCLC
Xiangya Hospital of Central South University
Observational
100
Changsha
2020-07-01
Active, closed
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721Non-small Cell Lung Cancer Stage II, Non-small Cell Lung Cancer Stage โ…ขA, Non-small Cell Lung Cancer Stage IIIB
Xiangya Hospital of Central South University
Phase 2
60
Changsha
2020-07-01
Recruiting
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NCT04688801Esophageal Cancer, Gastroesophageal Cancer, Immunotherapy, Adjuvant
The Second Hospital of Shandong University
Not applicable
200
Jinan
2020-07-01
Recruiting
Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer
NCT04518501Efficacy and Safety
Xing Xie
Phase 1/2
50
Zhejiang
2020-07-01
Recruiting
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
NCT04481932HER2-positive Breast Cancer
Peking University
Phase 2
104
Beijing
2020-07
By invitation
Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL
NCT04491721Diffuse Large B Cell Lymphoma
Chinese Academy of Medical Sciences
Observational
407
Beijing
2020-07
Recruiting
Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma
NCT04425265Surgery, Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicable
500
Guangzhou, Zhuhai, Nanchang
2020-06-30
Active, closed
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
NCT04273945Pulmonary Arterial Hypertension
Actelion
Phase 3
935
Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Shanghai, Shenyang, Tianjin
2020-06-30
Active, closed
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
NCT06728631Oral Cavity Cancer, Premalignant Lesion
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
22
Shanghai
2020-06-30
Recruiting
Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
NCT05847894Pulmonary Diseases, Ophthalmological Diagnostic Techniques, Artificial Intelligence
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
10,000
Guangzhou, Shenzhen
2020-06-29
Active, closed
Phase III Study of Toripalimab๏ผˆJS001๏ผ‰ Combined With Lenvatinib for Advanced HCC
NCT04523493Advanced Hepatocellular Carcinoma (HCC)
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Nanjing
2020-06-29
Recruiting
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
NCT04376866Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University
Phase 3
204
Nanning
2020-06-28
Active, closed
Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel
NCT04514419Breast Cancer
BioRay Pharmaceutical Co., Ltd.
Phase 3
408
Qingdao
2020-06-28
Not yet open
An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
NCT04443543Rectal Cancer
Fudan University
Phase 2
222
Shanghai
2020-06-22
Active, closed
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
NCT04232553Crohn's Disease
Eli Lilly and Company
Phase 3
996
Hefei, Chongqing, Xiamen, Foshan, Guangzhou, Wuhan, Changsha, Changzhou
2020-06-22
Recruiting
To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
NCT04547673Otolaryngological Disease, Artificial Intelligence
First Affiliated Hospital, Sun Yat-Sen University
Observational
1,000
Guangzhou, Macao
2020-06-20
Active, closed
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
NCT04270409Plasma Cell Myeloma
Sanofi
Phase 3
337
Hangzhou, Nanchang, Shanghai, Shenyang, Tianjin
2020-06-16
Active, closed
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
NCT04224493Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma
Epizyme, Inc.
Phase 3
599
Fuzhou, Xiamen, Guiyang, Zhejiang, Shijiazhuang, Zhengzhou, Changsha, Changchun
2020-06-11
Recruiting
Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement
NCT04432714DLBCL, Untreated, MYC Gene Rearrangement
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2
81
Nanjing
2020-06-09
Recruiting
TAES for FPVCs: a Pragmatic, Randomized Controlled Trial
NCT04415203Premature Ventricular Complexes
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Not applicable
90
Beijing
2020-06-04
Recruiting
Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
NCT04231565Hepatitis B Virus
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
200
Guangzhou
2020-06-04
Recruiting
Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients
NCT04440436NHL
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1/2
52
Beijing
2020-06-04
Recruiting
National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
NCT05437965Coronary Artery Disease, Arteritis, In-Stent Stenosis (Restenosis) of Coronary Artery Stent
China National Center for Cardiovascular Diseases
Observational
1,000
Beijing
2020-06-03
Active, closed
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)
NCT04379596Gastric Cancer
AstraZeneca
Phase 2
452
Chengdu, Guangzhou, Hefei, Shanghai, Shenyang, Wuhan, Zhengzhou
2020-06-03
Active, closed
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
NCT04922658Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2
76
Guangzhou
2020-06-03
Recruiting
Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA
NCT07829705Light Chain Cardiac Amyloidosis
Peking Union Medical College Hospital
Phase 2
60
Beijing
2020-06-03
Recruiting
MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
NCT04187443Diabetic Macular Edema, Macular Edema, Type 2 Diabetes With Diabetic Macular Edema, Type 1 Diabetes With Diabetic Macular Edema
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Phase 1
45
Changsha, Chengdu, Shanghai
2020-06-02
Recruiting
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
NCT04183712Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 2
102
Shanghai
2020-06-01
Active, closed
Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation
NCT07255716Infection, Driveline Heart-assisted Device Related Infection, Pneumonia, Sepsis
China National Center for Cardiovascular Diseases
Observational
120
Beijing
2020-06-01
Active, closed
Efficacy of HAD Induction With Intensified Cytarabine in Newly-diagnosed CEBPA Double Mutated Acute Myeloid Leukemia
NCT04415008CEBPA Double Mutation, Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
61
Tianjin
2020-06-01
By invitation
Environmental Factors and Myopia Prevalence Among Uyghur Students in Remote China
NCT07119723Myopia, Environment
Tianjin Medical University Eye Hospital
Observational
100,000
Tianjin
2020-06-01
Recruiting
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
NCT07504510Crohn's Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
300
Guangzhou
2020-06-01
Recruiting
Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery
NCT05270616Lung Diseases, Surgery
The Second Hospital of Shandong University
Not applicable
800
Jinan
2020-06-01
Recruiting
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
NCT05477979Lung Cancer, Psychological Stress, Immune Checkpoint Inhibitors, Cancer, Treatment-Related
Second Xiangya Hospital of Central South University
Observational
750
Changsha
2020-06-01
Not yet open
A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients
NCT04426136Breast Cancer, Elderly Patient, Wide Local Excision, Surgery
Peking Union Medical College Hospital
Observational
300
Beijing
2020-06
Active, closed
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227Esophagus Cancer, Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Radiation Therapy
Fudan University
Phase 2
70
Shanghai
2020-05-30
Active, closed
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
NCT04398914Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine
Phase 2
216
Shanghai
2020-05-30
Active, closed
Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease
NCT04397211Coronary Artery Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
1,872
Hangzhou, Beijing, Guangdong, Huzhou, Jinan, Jinhua, Kunming, Nanchang
2020-05-29
Active, closed
Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)
NCT04379635Non Small Cell Lung Cancer
BeiGene
Phase 3
453
Hefei, Beijing, Fuzhou, Quanzhou, Xiamen, Guangzhou, Jiangmen, Shantou
2020-05-29
Recruiting
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
NCT04575337Alzheimer Disease
Capital Medical University
Observational
6,000
Beijing
2020-05-28
Recruiting
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
NCT06084299Liver Cancer
Zhiyong Huang
Phase 1
16
Wuhan
2020-05-27
Recruiting
The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
NCT04409860Cervical Cancer
Chongqing University Cancer Hospital
Not applicable
120
Chongqing
2020-05-26
Active, closed
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
NCT04261673Epidural Hematoma, Brain Herniation, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Not applicable
120
Shanghai
2020-05-23
Recruiting
Long-Term Outcomes in SLE at Peking University People's Hospital
NCT07005479Systemic Lupus Erythematosus
Peking University People's Hospital
Observational
1,000
Beijing
2020-05-21
Active, closed
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
NCT04383275Breast Cancer
Fudan University
Phase 2
367
Shanghai
2020-05-20
Recruiting
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
NCT05713994Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD
Observational
300
Quanzhou, Wuhan
2020-05-19
Recruiting
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
NCT04310787Hepatitis B, Acute-On-Chronic Liver Failure
Third Affiliated Hospital, Sun Yat-Sen University
Observational
300
Guangzhou
2020-05-15
Recruiting
Real World Study of Classic Infectious Disease
NCT04020536Brucelloses, Epidemic Hemorrhagic Fever, Kala-Azar
Huashan Hospital
Observational
10,000
Shanghai
2020-05-13
Active, closed
Sustained Effect of Red-light Therapy for Myopia Control: A 2-Year Post-Trial Follow-up Study
NCT06232161Myopia
Beijing Airdoc Technology Co., Ltd.
Not applicable
50
Ningbo
2020-05-13
Recruiting
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage โ…ข Endometrial Cancer
NCT04453904Endometrial Cancer
Peking University People's Hospital
Not applicable
654
Beijing
2020-05-12
Recruiting
Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis
NCT04158843Breast Cancer, Oligometastasis
xuexin he
Not applicable
183
Hangzhou, Jiaxing, Lishui
2020-05-09
Active, closed
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
NCT04320979Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
2,400
Beijing
2020-05-08
Active, closed
Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
NCT04246047Multiple Myeloma
GlaxoSmithKline
Phase 3
494
Beijing, Jinan, Shenyang
2020-05-07
Active, closed
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
NCT04269200Endometrial Neoplasms
AstraZeneca
Phase 3
805
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Guangdong, Guangzhou
2020-05-05
Active, closed
A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy
NCT04371783IVF, Frozen Embryo Transfer
ShangHai Ji Ai Genetics & IVF Institute
Not applicable
828
Shanghai
2020-05-04
Active, closed
Time Restricted Eating on Impaired Glucose Regulation(TRIG Trial)
NCT03802253Impaired Glucose Regulation, Overweight/Obese, Time-restricted Eating
The First Affiliated Hospital of Xiamen University
Not applicable
142
Xiamen
2020-05-04
Recruiting
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)
NCT04365036NK/T Cell Lymphoma Nos
Sun Yat-sen University
Phase 3
207
Guangzhou
2020-05-03
Recruiting
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
NCT04574089Vaginitis
Peking University Shenzhen Hospital
Phase 3
50
Shenzhen
2020-05-01
Recruiting
Chinese Obesity and MEtabolic Surgery Database (COMES Database)
NCT06275061Obesity, Metabolic Surgery, Bariatric Surgery, Weight Loss
Jinan University Guangzhou
Observational
1,000,000
Guangzhou
2020-05-01
Recruiting
Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma ๏ผˆSPARE-01๏ผ‰
NCT05167994Sarcoma,Soft Tissue, Extremity, Trunk, Anlotinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing
2020-05-01
Recruiting
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
NCT05520788Hepatocellular Carcinoma, Biliary Tract Cancer
Tongji Hospital
Observational
200
Wuhan
2020-05-01
Active, closed
The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia
NCT04398459Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
18
Zhoukou, Taiโ€™an, Tianjin
2020-05-01
Recruiting
Correlation of Microbiome and Metabonomics With IgA Nephropathy
NCT05190848IgA Nephropathy
Guangdong Provincial People's Hospital
Observational
600
Guangzhou, Guanzhou
2020-05-01
Recruiting
Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass
NCT04220047Coronary Artery Disease, Stroke, Atrial Fibrillation
China National Center for Cardiovascular Diseases
Not applicable
400
Beijing
2020-04-30
Active, closed
Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies
NCT03932331Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic Leukemia
AstraZeneca
Phase 1/2
105
Beijing, Changchun, Changsha, Changzhou, Chengdu, Fuzhou, Haikou, Hangzhou
2020-04-29
Recruiting
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
NCT04422366Cervical Cancer, Vulvar Cancer, Vaginal Cancer, CIN1
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3
8,000
Liuzhou
2020-04-28
Recruiting
A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors
NCT04093466Advanced Solid Tumor
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 1
126
Beijing
2020-04-27
Recruiting
VitaFlowโ„ข Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study
NCT04414865Aortic Valve Stenosis
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Observational
100
Shanghai
2020-04-26
Active, closed
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
NCT03934567Lymphoma, Follicular
Xynomic Pharmaceuticals, Inc.
Phase 2
87
Beijing, Changchun, Chengdu, Dalian, Fuzhou, Guangzhou, Hainan, Hangzhou
2020-04-22
Recruiting
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
NCT04281641HER2-positive Breast Cancer
Fudan University
Not applicable
94
Shanghai
2020-04-21
Recruiting
Effectiveness of Bariatric Surgery for NAFLD/NASH
NCT04366999Bariatric Surgery Candidate, NAFLD, NASH With Fibrosis
Beijing Friendship Hospital
Observational
320
Beijing
2020-04-21
Recruiting
Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
NCT04280822Esophageal Cancer, Surgery, Neoadjuvant Treatment, Survival
Henan Cancer Hospital
Phase 3
400
Zhengzhou
2020-04-21
Active, closed
A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors
NCT04603287Locally Advanced or Metastatic Epithelial Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
60
Guangzhou, Chengdu, Hangzhou
2020-04-17
Active, closed
Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer
NCT04305496Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca
Phase 3
818
Baoding, Beijing, Changchun, Chongqing, Dalian, Foshan, Gongshu District, Guangzhou
2020-04-16
Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
NCT04322890Non Small Cell Lung Cancer, EGFR Gene Mutation, ALK Gene Mutation, ROS1 Gene Mutation
Hunan Province Tumor Hospital
Phase 2
6,000
Changsha
2020-04-16
Recruiting
The Taiwan OSA Study
NCT07302685Obstructive Sleep Apnea
China Medical University Hospital
Observational
7,000
2020-04-10
Recruiting
Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery
NCT04209218Lung Cancer, Surgery, Blood Pressure Management, Dexamethasone
Peking University First Hospital
Not applicable
1,988
Beijing
2020-04-07
Recruiting
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
NCT04142437Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Bayer
Observational
150
Multiple Locations
2020-04-03
Active, closed
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT04162210Multiple Myeloma
GlaxoSmithKline
Phase 3
325
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanchang, Shenzhen, Tianjin
2020-04-02
Active, closed
Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study
NCT06929884Prostate Cancers
Qianfoshan Hospital
Observational
400
Jinan
2020-04-02
Recruiting
Cognitive Impairment in Ageing People
NCT04360200MCI, Alzheimer Disease, VAD - Vascular Dementia, Cognitive Impairment
Yamei Tang
Observational
5,000
Guangzhou
2020-04-01
Recruiting
Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography
NCT05204108Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
1,000
Guangzhou
2020-04-01
Recruiting
Trigger Timing in Ovarian Stimulations
NCT04163133IVF Outcome
Peking University Third Hospital
Not applicable
834
Beijing
2020-04-01
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
NCT04544969Circulating Tumor Cell, Nasopharyngeal Carcinoma, Distant Metastases.Clinical, Effects of Chemotherapy
Sun Yat-sen University
Observational
50
Guangzhou
2020-04-01
Recruiting
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
NCT04085900Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China
Observational
40,000
Zhongshan, Wuzhou
2020-04-01
Active, closed
Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
NCT04223856Urothelial Cancer
Astellas Pharma Global Development, Inc.
Phase 3
886
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou
2020-03-30
Recruiting
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
NCT04215731Rectal Cancer
Yanhong Deng
Phase 3
582
Guangzhou
2020-03-27
Recruiting
Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
NCT04324151Non Small Cell Lung Cancer
Hunan Province Tumor Hospital
Observational
70
Changsha
2020-03-24
Recruiting
Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer
NCT04322617Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2/3
1,200
Changsha
2020-03-24
Recruiting
Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
NCT04324125Non Small Cell Lung Cancer
Hunan Province Tumor Hospital
Observational
70
Changsha
2020-03-24
Recruiting
Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC
NCT04324164Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Observational
800
Changsha
2020-03-24
Recruiting
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
NCT05321758Crohn Disease
Tongji Hospital
Not applicable
50
Wuhan
2020-03-22
Active, closed
Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
NCT04326153IIIA Stage Non-small Cell Lung Cancer
The First Hospital of Jilin University
Phase 2
30
Changchun
2020-03-20
Recruiting
National Registry of IRPF in China
NCT04314323Idiopathic Retroperitoneal Fibrosis
Peking Union Medical College Hospital
Observational
500
Beijing
2020-03-17
Rows per page Showing 18001–18100 of 19052
Previous 179 180 181 182 183 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=181

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.